What
image
  • imageAdvertising & Marketing
  • imageAutomotive
  • imageBusiness Dealerships
  • imageBusiness Services
  • imageEducation
  • imageFood & Beverage
  • imageHealth & Beauty
  • imageHome Based
  • imageHome Services
  • imageOthers
  • imagePet
  • imageRetail
  • imageTravel & Leisure
Where
image
image
At a glance
10K - 50K
Investment Range
26 - 50
Franchise Count
101 - 500 sq.ft
Area Required
18 - 24 months
Payback Period
1
Years in Franchising

About the brand

Ethixelite Lifesciences Private Limited Franchise

Franchise Quick Facts

Brand Name EthixElite Lifesciences Private Limited
Industry / Business Category Pharmacies / Pharmaceutical Services
Founded Year 2024
Franchise Started Year 2024
Total Franchise Outlets 20–50
Estimated Investment INR 10,000 – 50,000
Franchise Fee Not separately specified
Royalty Fee Not specified
Space Requirement 100–200 Sq.ft
Staff Requirement Not specified
Expected Payback Period 1–2 Years

1. What is EthixElite Lifesciences?

EthixElite Lifesciences is a pharmaceutical franchise operating in the healthcare sector. It offers ethically manufactured medications, branded generics, and contract manufacturing solutions to healthcare providers, businesses, and patients. The brand serves pharmacies, clinics, and healthcare institutions seeking reliable, compliant, and affordable pharmaceutical products.

2. How the Business Works

Franchise outlets function as retail and distribution points for EthixElite’s pharmaceutical products. Customers, including pharmacies and healthcare institutions, purchase medicines and healthcare products directly from the franchise. Revenue is generated through the sale of pharmaceutical products, including branded generics, therapeutic medicines, and contract-manufactured items. Franchisees follow operational protocols to ensure product safety, regulatory compliance, and proper inventory management.

3. Products or Services Offered

Branded Generics Pharmaceutical drugs manufactured under EthixElite’s brand name
Contract Manufacturing Production services enabling clients to launch regulatory-compliant medications under their own branding
Therapeutic Categories Multiple healthcare areas including general medicines, specialty therapeutics, and over-the-counter products
B2B Services Supply to hospitals, pharmacies, clinics, and healthcare distributors

4. How the Franchise Model Works

Franchise partners operate local retail or distribution outlets, acting as points of sale for EthixElite products. The franchise owner manages daily operations, inventory, customer interactions, and local marketing. EthixElite provides product sourcing, quality control standards, regulatory compliance guidance, and operational support. The relationship emphasizes ethical practices, consistent product quality, and adherence to healthcare regulations.

5. Franchise Cost and Investment Overview

Estimated Investment INR 10,000 – 50,000 depending on outlet location and scale
Setup Cost Components Initial inventory procurement, store setup, licensing, and basic operational equipment
Royalty / Ongoing Fees Not specified; structured according to franchise agreement

6. Space and Infrastructure Requirements

Space Requirement 100–200 Sq.ft
Preferred Locations Accessible urban or semi-urban areas with foot traffic or proximity to healthcare providers
Equipment Needs Shelving, storage for medicines, point-of-sale systems
Staffing Requirements Staff to handle inventory management and customer service (number depends on outlet scale)

7. Training and Franchise Support

  • Operational training on inventory management and sales processes
  • Guidance on regulatory compliance and drug handling procedures
  • Marketing support including promotional material and awareness campaigns
  • Assistance with supplier coordination and product sourcing
  • Ongoing guidance to ensure ethical practices and quality standards

8. Revenue Model and ROI Factors

Revenue is primarily generated through the sale of pharmaceutical products to pharmacies, clinics, and healthcare institutions. Repeat purchase potential is high due to recurring demand for medications and healthcare supplies. Operational cost considerations include inventory management, compliance costs, and local marketing. Payback periods are estimated at 1–2 years, influenced by local demand, outlet location, and sales efficiency.

9. Brand Background and Expansion

Established Year 2024
Franchise Commencement 2024
Current Franchise Outlets 20–50
Geographic Reach Domestic expansion across cities with potential for rural and urban penetration
Expansion Plans Scaling franchise network and increasing presence in regulated pharmaceutical distribution

10. Key Advantages of the Franchise Opportunity

  • Ethical and regulated pharmaceutical brand with structured product portfolio
  • Multiple revenue streams from branded generics and contract manufacturing
  • Scalable business model suitable for small retail and distribution setups
  • Support for operations, compliance, and marketing
  • Opportunity to enter a growing healthcare sector with rising medication demand

11. Who Should Consider This Franchise

  • Entrepreneurs seeking entry into the pharmaceutical or healthcare sector
  • Individuals interested in ethical business practices with recurring revenue potential
  • Investors looking for small-scale, manageable retail or distribution operations
  • Professionals with knowledge of local healthcare markets or pharmacy operations

13. Similar Franchise Opportunities

  • Apollo Pharmacy – Retail pharmacy chain with domestic and urban presence
  • MedPlus – Pharmacy and healthcare retail services
  • Netmeds – Pharmaceutical distribution and online pharmacy services
  • Guardian Pharmacy – Health and wellness retail outlets
  • CarePoint – Retail pharmacy franchise with integrated supply chain
Health & Beauty Pharmacies B2C Owner-Operated Individual

Investment and financials

Cost overview
Investment range10K - 50K
Franchise / Brand feeAvailable on inquiry
Royalty / CommissionAvailable on inquiry
Investment tierLow
Area required101 - 500 sq.ft
Staff required2 - 6
Setup complexityModerate
Renewal availableYes
Returns outlook
Expected monthly revenue
Available on inquiry
Revenue levelLow
Business modelB2C
Capital payback18 - 24 months
Capital sensitivityVery High

Investor fit profile

Operations
Operation modeOwner-Operated
Location typeResidential/High Street
Home-based possibleNo
Can run part-timeNo
Primary customerIndividual
Market characteristics
SeasonalityVery High
Recession resistanceHigh
Digital integrationHigh
Years in franchising1 years
Ideal for
Homemaker Student Salaried Professional seeking side income Pharmacist

Franchise support

Training and agreement details
Renewal available
Yes

Brand strength

1
Years Franchising
2024
Founded
C
Brand Tier
C
Tier C — Startup brand
A+Established AMature BGrowing CStartup
Startup

Forefind rank history

#78#87#96#105202420252024: #1092025: #81
Current rank
#81
#81 of 120 in Pharmacies
2025
Moved up 28 places since 2024
Based on Forefind scoring model

Licences and compliance

Required licences and registrations for operating this franchise in India. Requirements may vary by state and city tier.
Drug License
GST
Setup complexity: Moderate

Frequently asked questions

Investment ranges from INR 10,000 to 50,000 depending on outlet location, inventory, and setup requirements.

Franchisees operate retail or distribution points selling pharmaceutical products, following operational and compliance protocols from the franchisor.

A space of 100–200 Sq.ft is recommended, suitable for retail display, inventory storage, and customer service.

Typical payback period is 1–2 years, depending on outlet performance and local demand.

Prospective franchisees can contact EthixElite for onboarding, operational training, and guidance to set up the pharmacy or distribution outlet. ## 13. Similar Franchise Opportunities

Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.

image